Skip to main content
Top

Clinical and Translational Oncology

Issue 4/2014

Content (11 Articles)

News & Views

Obituary

P. C. Lara

Educational Series - Blue Series

Epidermal growth factor receptor tyrosine-kinase inhibitor treatment resistance in non-small cell lung cancer: biological basis and therapeutic strategies

S. Carrera, A. Buque, E. Azkona, U. Aresti, B. Calvo, A. Sancho, M. Arruti, M. Nuño, I. Rubio, A. R. de Lobera, C. Lopez, G. L. Vivanco

Educational Series—Red Series

Breast cancer management in the elderly

M. Luque, F. Arranz, J. F. Cueva, A. de Juan, P. García-Teijido, L. Calvo, I. Peláez, A. García-Palomo, J. García-Mata, S. Antolín, L. García-Estévez, Y. Fernández

Special Article

Guidelines for biomarker testing in metastatic melanoma: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

S. Martín-Algarra, M. T. Fernández-Figueras, J. A. López-Martín, A. Santos-Briz, A. Arance, M. D. Lozano, A. Berrocal, J. J. Ríos-Martín, E. Espinosa, J. L. Rodríguez-Peralto

Research Article

Identification of microRNAs associated with lymphangiogenesis in human gastric cancer

B. Yang, C. Jing, J. Wang, X. Guo, Y. Chen, R. Xu, L. Peng, J. Liu, L. Li

Research Article

Assignment of tumor subtype by genomic testing and pathologic-based approximations: implications on patient’s management and therapy selection

A. Romero, A. Prat, J. Á. García-Sáenz, N. del Prado, A. Pelayo, V. Furió, J. M. Román, M. de la Hoya, E. Díaz-Rubio, C. M. Perou, T. Cladés, M. Martín

Research Article

Comparison of tumor neovasculature-targeted paramagnetic nanoliposomes for MRI in mice xenograft models

Q.-H. Xu, J.-Y. Shi, J. Zhang, Y.-F. Sun, A. H. Chang, Y.-M. Zhao, W.-J. Cai, D. Liu, C.-C. Zhou, L.-H. Fan, B. Su

Research Article

CMTM3 is frequently reduced in clear cell renal cell carcinoma and exhibits tumor suppressor activities

J. Xie, Y. Yuan, Z. Liu, Y. Xiao, X. Zhang, C. Qin, Z. Sheng, T. Xu, X. Wang

Research Article

H19 DMR methylation correlates to the progression of esophageal squamous cell carcinoma through IGF2 imprinting pathway

T. Gao, B. He, Y. Pan, L. Gu, L. Chen, Z. Nie, Y. Xu, R. Li, S. Wang

Research Article

Concurrent radiotherapy plus epidermal growth factor receptor inhibitors in patients with human papillomavirus-related head and neck cancer

B. Pajares, L. Perez-Villa, J. M. Trigo, M. D. Toledo, M. Álvarez, B. Jimenez, J. A. Medina, V. de Luque, J. M. Jerez, E. Alba

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine